Related Experiment Video
Updated: Jan 20, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Hepatocellular metastasis recurrence in liver transplant after treatment with direct antiviral agents
Silvia Maier1, Debora Donnini1, Laura De Luca1
1Liver Unit, Internal Medicine, Department of Medicine (DAME), University School of Medicine of Udine, Piazzale S. M. Misericordia 1, 33100, Udine, Italy.
Abstract:
Chronic HCV liver infection is considered one of the main causes of liver cirrhosis and hepatocellular carcinoma (HCC). For a selected group of patients, orthotopic liver transplantation (OLTx) is the most effective option to cure both liver diseases. After liver transplantation, patients may be at risk of viral infection reactivation and HCC recurrence. HCV recurrence on the transplanted organ can lead to graft cirrhosis and therefore the clearance of virus with antiviral therapies has a pivotal role on the prevention of graft damage. Nowadays, direct antiviral agents (DAAs) represent the choice treatment for HCV recurrence in liver transplanted patients, ensuring high eradication rates. We present the case of a liver transplant recipient who developed, 7 years after OLTx and immediately after a DAAs treatment, a subcutaneous abdominal mass with histological characteristics of HCC.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
The Antiviral System of Bacteria and Archaea: CRISPR

